Disulfiram self poisoning is exceptional. The authors report on the case of such an intoxication related to the ingestion of a potentially lethal dose of this drug (30 g) and draw the attention on the following points: 1) The initial signs may be misleading because they include both psychiatrics and neurological signs such as phonation abnormalities, myoclonias and tetraparesia. 2) The evolution is unforseeable with the possible occurrence of severe psychological and motricity sequaelae, associated with bilateral and symetric injuries of the putamen, the palladium and the basal nuclei on CT-scan (or MRI). The pathophysiologic al mechanisms of theses signs are discussed, and the need for disulfiram in the care of alcoholic patients seeking for withdrawal as well.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Disulfiram-induced psychosis still an important clinical entity: A case series.
Ind Psychiatry J
August 2024
Department of Psychiatry, INHS Asvini, Mumbai, Maharashtra, India.
Disulfiram, an FDA-approved medication for treating alcohol dependence syndrome (ADS), is often used surreptitiously, resulting in severe adverse drug reactions such as disulfiram-induced psychosis (DIP). DIP presents diagnostic challenges, despite being perceived as common; however, there is limited literature available on DIP in India. We describe four cases with a history of psychosis in the background of disulfiram exposure.
View Article and Find Full Text PDFSelective Inhibition of Deamidated Triosephosphate Isomerase by Disulfiram, Curcumin, and Sodium Dichloroacetate: Synergistic Therapeutic Strategies for T-Cell Acute Lymphoblastic Leukemia in Jurkat Cells.
Biomolecules
October 2024
Laboratorio de Biomoléculas y Salud Infantil, Instituto Nacional de Pediatría, Mexico City 04530, Mexico.
T-cell acute lymphoblastic leukemia (T-ALL) is a challenging childhood cancer to treat, with limited therapeutic options and high relapse rates. This study explores deamidated triosephosphate isomerase (dTPI) as a novel therapeutic target. We hypothesized that selectively inhibiting dTPI could reduce T-ALL cell viability without affecting normal T lymphocytes.
View Article and Find Full Text PDFProlonged Retention of Albumin Nanoparticles Alleviates Renal Ischemia-Reperfusion Injury through Targeted Pyroptosis.
ACS Appl Mater Interfaces
November 2024
Department of Nephrology, Huai'an Key Laboratory of Chronic Kidney Disease, The Affiliated Huai'an Hospital of Xuzhou Medical University and Huai'an Second People's Hospital, Huai'an 223002, China.
Acute kidney injury (AKI) represents a prevalent and complex clinical event, characterized by irreversible damage to renal tubular epithelial cells and high intensive care unit (ICU) admission rates and mortality. The kidneys are highly susceptible to oxidative stress, inflammation, pyroptosis, and programmed cell death. Pyroptosis poses a significant risk, exacerbating the damage and inflammation of renal tubular cells.
View Article and Find Full Text PDFRole of cuproptosis in mediating the severity of experimental malaria-associated acute lung injury/acute respiratory distress syndrome.
Parasit Vectors
October 2024
Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, Guangdong Pharmaceutical University, Guangzhou, 510006, People's Republic of China.
Article Synopsis
- The study investigates how cuproptosis, a process triggered by copper accumulation, influences the severity of malaria-associated acute lung injury/acute respiratory distress syndrome (MA-ALI/ARDS) caused by Plasmodium falciparum infection.
- Using a mouse model infected with P. berghei ANKA, researchers assessed the impact of copper ion carrier disulfiram and copper ion chelator tetrathiomolybdate on lung injury and inflammation.
- Results showed increased copper levels and macrophage polarization in the lungs of mice treated with disulfiram, indicating that cuproptosis may play a significant role in the development of MA-ALI/ARDS.
Background: The US Department of Veterans Affairs, Department of Defense (VA/DoD) clinical guidelines recommend extended-release naltrexone (XR-NTX) as a treatment option for moderate-to-severe alcohol use disorder (AUD); however, contemporary real-world outcomes related to this guideline are lacking. This retrospective, observational, descriptive study examined treatment patterns and healthcare resource use (HCRU) among veterans with an AUD diagnosis who initiated XR-NTX.
Methods: Veterans with incident AUD who initiated XR-NTX between 8/2014 and 11/2018 were identified.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!